Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
OCREVUS Inf Konz 300 mg/10 ml Durchstf 10 ml
Drug
Ocrevus, Konzentrat zur Herstellung einer Infusionslösung
Multiple Sklerose
01.99.0. – various
HAM – Human medicine
KOINF – Concentrate for solution for infusion
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
9/20/2017
12/31/9999
Dosage strength
Ocrevus, Konzentrat zur Herstellung einer Infusionslösung
Multiple Sklerose
01
Z – approved
Package
7680661850010
In trade from / since 9/20/2017
A/R – Authorised / referenced
1 vial(s)
001
Z – approved
Declaration
Component
300 mg ocrelizumabum
natrii acetas trihydricus
acidum aceticum glaciale
trehalosum dihydricum
polysorbatum 20
aqua ad iniectabile
3.6 mg natrium
acidum aceticum glaciale
trehalosum dihydricum
polysorbatum 20
aqua ad iniectabile
3.6 mg natrium
Spezialitätenliste***
SL
-
-
5770.70
None
Yes
10%
No
Authorisation holder
7601001010208
Roche Pharma (Schweiz) AG
Grenzacherstrasse 124
4058 Basel (BS)
Grenzacherstrasse 124
4058 Basel (BS)
Date of revision of the text
5/9/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.